Clinical Trial Update: A Study Of Different Doses Of TBC3711 In Patients With Uncontrolled High Blood Pressure Already Taking Medications For High Blood Pressure. [Phase 2]

View source ↗

Summary

Phase 2 study evaluating different doses of TBC3711 in patients with resistant hypertension already on medications; the trial was terminated with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Resistant Hypertension

Drugs mentioned

• TBC3711

Snippet

Sponsor: Pfizer | Conditions: Resistant Hypertension | Phase 2 | Status: TERMINATED | Results posted: 2013-03-05